1. Home
  2. XPL vs SCLX Comparison

XPL vs SCLX Comparison

Compare XPL & SCLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Solitario Resources Corp.

XPL

Solitario Resources Corp.

HOLD

Current Price

$0.73

Market Cap

68.9M

ML Signal

HOLD

Logo Scilex Holding Company

SCLX

Scilex Holding Company

HOLD

Current Price

$6.84

Market Cap

55.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
XPL
SCLX
Founded
1984
2011
Country
United States
United States
Employees
N/A
34
Industry
Precious Metals
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
68.9M
55.1M
IPO Year
2000
N/A

Fundamental Metrics

Financial Performance
Metric
XPL
SCLX
Price
$0.73
$6.84
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$1.20
N/A
AVG Volume (30 Days)
64.3K
106.3K
Earning Date
05-04-2026
04-10-2026
Dividend Yield
N/A
N/A
EPS Growth
42.86
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$122.52
Revenue Next Year
N/A
$186.30
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.54
$4.20
52 Week High
$0.98
$34.27

Technical Indicators

Market Signals
Indicator
XPL
SCLX
Relative Strength Index (RSI) 50.42 41.02
Support Level $0.69 $5.72
Resistance Level $0.79 $7.77
Average True Range (ATR) 0.03 1.02
MACD 0.00 -0.26
Stochastic Oscillator 66.67 4.02

Price Performance

Historical Comparison
XPL
SCLX

About XPL Solitario Resources Corp.

Solitario Resources Corp is an exploration company engaging in acquiring, exploring, and developing zinc properties and other precious metals in safe jurisdictions in North and South America. Its core mineral property assets are: the Florida Canyon zinc project in Peru, the Lik zinc project in Alaska, and the Golden Crest project in South Dakota. Additionally, Solitario holds an interest in the Chambara project in Peru and also has two early-stage projects, the Cat Creek project and the Bright Angel project in Colorado. The company is conducting mineral exploration on its Golden Crest project, the Cat Creek project, and the Bright Angel project on its own.

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. It targets indications with high unmet needs and large market opportunities with non-opioid therapies for the treatment of patients with acute and chronic pain and are dedicated to advancing and improving patient outcomes. Its commercial products are: ZTlidoO for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a potential first-line treatment ready-to-use oral solution for the acute treatment of migraine in adults and GLOPERBA, the liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults.

Share on Social Networks: